We serve Chemical Name:1-benzyl-3-hydroxypyrrolidine-2,5-dione CAS:78027-57-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-benzyl-3-hydroxypyrrolidine-2,5-dione
CAS.NO:78027-57-3
Synonyms:N-benzyl-3-hydroxysuccinimide;N-benzylmalimide;(RS)-N-benzyl-3-hydroxypyrrolidine-2,5-dione;(+-)-N-Benzyl-aepfelsaeure-imid;1-benzyl-3-hydroxy-2,5-pyrrolidinedione;1-Benzyl-3-hydroxy-pyrrolidin-2,5-dion;1-benzyl-3-hydroxy-pyrrolidine-2,5-dione
Molecular Formula:C11H11NO3
Molecular Weight:205.21000
HS Code:2925190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:57.61000
Exact Mass:205.07400
LogP:0.24430
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-benzyl-3-hydroxysuccinimide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-3-hydroxy-pyrrolidine-2,5-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-3-hydroxy-pyrrolidine-2,5-dione Use and application,N-benzyl-3-hydroxysuccinimide technical grade,usp/ep/jp grade.
Related News: The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” 1-benzyl-3-hydroxypyrrolidine-2,5-dione manufacturer The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” 1-benzyl-3-hydroxypyrrolidine-2,5-dione supplier Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 1-benzyl-3-hydroxypyrrolidine-2,5-dione vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 1-benzyl-3-hydroxypyrrolidine-2,5-dione factory The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.”
